Stephen Boyd Wiles 13D and 13G filings for Clearside Biomedical, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-01 06:09 am Purchase | 2025-03-31 | 13G | CLEARSIDE BIOMEDICAL INC CLSD | Stephen Boyd Wiles | 266,904 5.200% | 266,904 (New Position) | Filing |